Comparison of cilofungin and amphotericin B for therapy of murine candidiasis
- 1 August 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (8) , 1619-1621
- https://doi.org/10.1128/aac.34.8.1619
Abstract
We compared the efficacies of cilofungin and amphotericin B treatment in a murine model of disseminated candidiasis. Three different dosages of each drug plus controls were evaluated. Statistically improved survival was noted only among mice treated with 1 mg of amphotericin B per kg of body weight (P less than 0.05). While all amphotericin B regimens and the two lower-dosage cilofungin regimens significantly reduced yeast cell counts in kidneys compared with the controls, the amphotericin B-treated mice had a significantly higher percentage of sterile kidneys following therapy compared with those treated with cilofungin (P = 0.0001).This publication has 13 references indexed in Scilit:
- Evaluation of cilofungin (LY121019) for treatment of experimental Candida albicans endocarditis in rabbitsAntimicrobial Agents and Chemotherapy, 1989
- pH and other effects on the antifungal activity of cilofungin (LY121019)Antimicrobial Agents and Chemotherapy, 1989
- Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agentsDiagnostic Microbiology and Infectious Disease, 1989
- Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activityAntimicrobial Agents and Chemotherapy, 1988
- Anti-Candida Activity and Toxicology of LY121019, a Novel Semisynthetic Polypeptide Antifungal AntibioticAnnals of the New York Academy of Sciences, 1988
- Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalisAntimicrobial Agents and Chemotherapy, 1988
- Comparative in vitro activity of LY121019 and amphotericin B against clinical isolates ofCandida speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Evaluation of in vitro antifungal activity of LY121019European Journal of Clinical Microbiology & Infectious Diseases, 1988
- Echinocandin inhibition of 1,3‐β‐D‐glucan synthase from Candida albicansFEBS Letters, 1984
- In vitro and in vivo anti-Candida activity and toxicology of LY121019.The Journal of Antibiotics, 1984